Full VWF mutation screen (Type 1 & Type 3 VWD)

Description
Analysis of the VWF gene by PCR amplification and sequencing of the coding region and splice junctions. Dosage analysis, via MLPA, is available as a second line test where gross deletions/ insertions are suspected.
Clinical details
Von Willebrand Disease is the most common hereditary bleeding disorder, typically associated with mucocutaneous bleeding (epitaxis, menorrhagia), easy bruising and bleeding post dental extraction. Type 1 VWD is autosomal dominant, with an estimated frequency of approximately 1:100-1000. It is generally clinically & phenotypically mild, although severe Type 1 VWD is seen and there is sometimes variable penetrance within families. Mutations are heterogeneous and spread throughout the VWF gene. Type 3 VWD is autosomal recessive and results in severe deficiency of plasma VWF. Patients suffer severe bleeding symptoms including hemarthroses, gastrointestinal bleeds and cerebral hemorrhage. Frequency is estimated at 1:500,000 to 1:2,000,000.
Related condition
Reference range

n/a

Units
n/a
Synonyms
VWF Von Willebrand disease Type 1 VWD Type 3 VWD
Testing site
Synnovis : Genomics : St Thomas' Hospital
Laboratory
Molecular Haemostasis
Sample type and volume required
1 x Edta
Call in advance
no
Storage and transport
transport at ambient temperature
Turnaround time
12 weeks
Contacts

Molecular Haemostasis Laboratory at St Thomas’ Hospital
Phone: 020 7188 2798
Haemostasis and Thrombosis
North Wing – 4th floor
St Thomas’ Hospital
Westminster Bridge Road
London SE1 7EH
Laboratory opening times
Monday – Friday 09.00 – 17.00

Last updated:

Back to search